Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Icosavax Inc.

    NASDAQ: ICVX · Real-Time Price · USD
    15.31
    -0.14 (-0.91%)
    At close: Feb 16, 2024, 9:00 PM

    Icosavax Statistics

    Share Statistics

    Icosavax has 50.23M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 50.23M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,030

    FTD / Avg. Volume

    n/a
    		 0.1%

    Short Selling Information

    The latest short interest is 289.43K, so 0.58% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 289.43K

    Short % of Shares Out

    n/a
    		 0.58%

    Short % of Float

    n/a
    		 0.97%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -3.57 and the forward PE ratio is null. Icosavax's PEG ratio is 0.09.

    PE Ratio

    n/a
    		 -3.57

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 541.95

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.45

    P/FCF Ratio

    n/a
    		 -4.33

    PEG Ratio

    n/a
    		 0.09
    Financial Ratio History

    Enterprise Valuation

    Icosavax has an Enterprise Value (EV) of 265.37M.

    EV / Sales

    n/a
    		 455.96

    EV / EBITDA

    n/a
    		 -2.79

    EV / EBIT

    n/a
    		 -4.3

    EV / FCF

    n/a
    		 -3.65

    Financial Position

    The company has a current ratio of 16.24, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 16.24

    Quick Ratio

    n/a
    		 16.24

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.09

    Debt / FCF

    n/a
    		 -0.12

    Interest Coverage

    n/a
    		 28.81

    Financial Efficiency

    Return on Equity is -40.55% and Return on Invested Capital is -40.38%.

    Return on Equity

    n/a
    		 -40.55%

    Return on Assets

    n/a
    		 -37.06%

    Return on Invested Capital

    n/a
    		 -40.38%

    Revenue Per Employee

    n/a
    		 $9,700

    Profits Per Employee

    n/a
    		 $-1,474,300

    Employee Count

    n/a
    		 60

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -3.3M

    Effective Tax Rate

    n/a
    		 3.6%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 1.28, so Icosavax's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.28

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 15.45

    200-Day Moving Average

    n/a
    		 10.38

    Relative Strength Index (RSI)

    n/a
    		 55.41

    Average Volume (20 Days)

    n/a
    		 1,053,296

    Income Statement

    In the last 12 months, Icosavax had revenue of 582K and earned -88.46M in profits. Earnings per share was -2.23.

    Revenue

    n/a
    		 582K

    Gross Profit

    n/a
    		 -1.26M

    Operating Income

    n/a
    		 -95.06M

    Net Income

    n/a
    		 -88.46M

    EBITDA

    n/a
    		 -95.06M

    EBIT

    n/a
    		 -95.06M

    Earnings Per Share (EPS)

    n/a
    		 -2.23
    Full Income Statement

    Balance Sheet

    The company has 58.85M in cash and 8.79M in debt, giving a net cash position of 50.05M.

    Cash & Cash Equivalents

    n/a
    		 58.85M

    Total Debt

    n/a
    		 8.79M

    Net Cash

    n/a
    		 50.05M

    Retained Earnings

    n/a
    		 -185.83M

    Total Assets

    n/a
    		 251.3M

    Working Capital

    n/a
    		 222.28M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -61.67M and capital expenditures -11.11M, giving a free cash flow of -72.79M.

    Operating Cash Flow

    n/a
    		 -61.67M

    Capital Expenditures

    n/a
    		 -11.11M

    Free Cash Flow

    n/a
    		 -72.79M

    FCF Per Share

    n/a
    		 -1.83
    Full Cash Flow Statement

    Margins

    Gross margin is -216.67%, with operating and profit margins of -16332.99% and -15198.97%.

    Gross Margin

    n/a
    		 -216.67%

    Operating Margin

    n/a
    		 -16332.99%

    Pretax Margin

    n/a
    		 -15765.98%

    Profit Margin

    n/a
    		 -15198.97%

    EBITDA Margin

    n/a
    		 -16332.99%

    EBIT Margin

    n/a
    		 -16332.99%

    FCF Margin

    n/a
    		 -12506.53%

    Dividends & Yields

    ICVX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -28.04%

    FCF Yield

    n/a
    		 -23.08%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ICVX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 22.59

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist